73 related articles for article (PubMed ID: 621423)
1. Effects of extravascular clotting on fibrinopeptide A levels in blood.
Wilner GD; Chatpar P; Te A; Horowitz J
J Lab Clin Med; 1978 Feb; 91(2):205-13. PubMed ID: 621423
[No Abstract] [Full Text] [Related]
2. [Biological properties of fibrinogen degradation products by thrombin].
Buczko W
Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
[No Abstract] [Full Text] [Related]
3. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
Gurrieri MA
Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
[TBL] [Abstract][Full Text] [Related]
4. [Endogenous peptides--physiological regulators of coagulative conversion of fibrinogen].
Byshevskiĭ ASh; Chiriat'ev EA; Leonova OP
Gematol Transfuziol; 1991 Apr; 36(4):28-31. PubMed ID: 2065963
[No Abstract] [Full Text] [Related]
5. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
Bell WR; Shapiro SS; Martinez J; Nossel HL
J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
[TBL] [Abstract][Full Text] [Related]
6. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinopeptide].
Shibusawa K
Kango; 1981 Apr; 33(4):82. PubMed ID: 6911340
[No Abstract] [Full Text] [Related]
8. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
9. The utility of plasma fibrinopeptide assays.
Owen J
Thromb Haemost; 1989 Sep; 62(2):807-10. PubMed ID: 2814929
[No Abstract] [Full Text] [Related]
10. Fibrin precursors, intermediaries for hemostasis in the clot war.
Shainoff JR; DiBello PM
Thromb Res; 2002 Jan; 105(1):3-13. PubMed ID: 11864700
[No Abstract] [Full Text] [Related]
11. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro.
Biedermann B; Rosenmund A; Muller M; Kohler HP; Haeberli A; Straub PW
J Lab Clin Med; 1994 Sep; 124(3):339-47. PubMed ID: 8083577
[TBL] [Abstract][Full Text] [Related]
12. Measurement of fibrinopeptide A in canine blood-an interim report.
Wilner GD
Thromb Res; 1979; 15(5-6):601-10. PubMed ID: 494165
[No Abstract] [Full Text] [Related]
13. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
15. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
16. An in vitro evaluation of the hemostatic activity of topical agents.
Eloy R; Baguet J; Christé G; Rissoan MC; Paul J; Belleville J
J Biomed Mater Res; 1988 Feb; 22(2):149-57. PubMed ID: 3356713
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the physiological pathway of clotting of fibrinogen in blood plasma.
Lorand L
Biophys Chem; 2004 Dec; 112(2-3):141-5. PubMed ID: 15572241
[TBL] [Abstract][Full Text] [Related]
18. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
19. Preeclampsia is not associated with excess fetal clotting.
Weiner C; Keller S
Obstet Gynecol; 1986 Dec; 68(6):871-2. PubMed ID: 3785801
[TBL] [Abstract][Full Text] [Related]
20. Congenital dysfibrinogenemia.
Rupp C; Beck EA
Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
